Demant CEO highlights strong performance from Diagnostics, acknowledges Communications letdown
Demant has had a tough second quarter, which has impacted the hearing aid manufacturer’s results for the first half of 2022 to such a degree it had to downgrade its full year guidance on Tuesday.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Demant downgrades after revenue disappoints
For subscribers